Saturday 17 October 2026
Export ITGR’s income statement to Excel — free account
Integer Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024. In the quarter to June 2026, revenue fell 2.60%, EPS fell 34.9%, free cash flow grew 48.8% and total debt rose 4.96%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
126.70
0.02
−0.02%
Follow ITGR
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
26.86 | 37.22 | 36.12 | 34.24 | 29.21 | 34.55 | 27.17 | 14.67 | 21.62 | 155.53 |
Piotroski F-Score |
6 | 8 | 8 | 4 | 7 | 5 | 5 | 5 | 6 | 7 |
P/S ratio |
1.47 | 2.59 | 2.10 | 1.70 | 2.31 | 2.48 | 2.09 | 2.02 | 1.25 | 0.85 |
Altman Z-Score |
2.34 | 3.19 | 2.63 | 2.08 | 2.50 | 2.51 | 2.45 | 2.24 | 1.20 | 0.94 |
P/FCF ratio |
26.17 | 45.05 | 58.80 | 60.19 | 28.51 | 20.52 | 22.39 | 19.80 | 13.91 | 19.25 |
Altman Z″-Score (non-manufacturers) |
3.52 | 3.51 | 3.23 | 2.93 | 3.03 | 2.98 | 2.73 | 2.52 | 1.72 | 1.48 |
Beneish M-Score |
(2.30) | (2.56) | (2.59) | (2.40) | (2.50) | (2.76) | (2.47) | (2.65) | (2.67) | (2.63) |
P/Operating CF |
49.16 | 70.42 | 58.89 | 43.96 | 71.93 | 37.51 | 49.16 | 52.63 | 42.20 | 26.96 |
P/B ratio |
1.56 | 2.75 | 2.15 | 1.60 | 2.08 | 2.10 | 2.28 | 2.31 | 1.60 | 1.25 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.12 | 3.16 | 2.72 | 2.39 | 2.98 | 3.12 | 2.72 | 2.76 | 2.64 | 2.41 |
EV/EBITDA |
10.93 | 16.76 | 15.65 | 15.37 | 16.25 | 16.36 | 14.08 | 11.41 | 12.52 | 13.57 |
EV/Operating CF |
19.99 | 26.41 | 23.47 | 27.30 | 23.24 | 18.47 | 20.72 | 20.03 | 20.07 | 24.52 |
EV/FCF |
37.66 | 54.83 | 75.98 | 84.31 | 36.77 | 25.76 | 29.23 | 27.07 | 29.24 | 54.77 |
Quick Ratio |
1.57 | 1.28 | 1.15 | 1.12 | 1.28 | 1.33 | 1.15 | 1.28 | 1.11 | 1.46 |
Current Ratio |
3.32 | 2.95 | 2.80 | 2.50 | 2.84 | 2.64 | 2.32 | 2.53 | 2.55 | 2.79 |
Net Debt/EBITDA |
3.33 | 2.99 | 3.50 | 4.40 | 3.65 | 3.33 | 3.29 | 3.06 | 6.57 | 8.80 |
Debt/Assets |
35.59% | 32.94% | 32.97% | 33.40% | 32.36% | 30.83% | 34.63% | 39.78% | 56.49% | 61.08% |
Debt/Equity |
0.69 | 0.63 | 0.64 | 0.66 | 0.62 | 0.58 | 0.71 | 0.87 | 1.80 | 2.39 |
Asset Turnover |
0.57 | 0.57 | 0.54 | 0.50 | 0.49 | 0.45 | 0.54 | 0.47 | 0.40 | 0.37 |
Operating CF/Net income |
1.91 | 1.71 | 1.99 | 1.75 | 1.62 | 2.35 | 1.72 | 1.00 | 2.24 | 17.70 |
Capex/Depreciation |
(0.66) | (0.92) | (1.12) | (0.79) | (0.60) | (0.61) | (0.56) | (0.32) | (0.41) | (0.60) |
Interest Coverage |
5.12 | 3.69 | 3.19 | 3.02 | 4.29 | 3.16 | 3.00 | 1.57 | 1.96 | 1.36 |
| 6.11% | 7.64% | 6.17% | 4.79% | 7.37% | 6.38% | 8.71% | 17.19% | 8.24% | 0.76% | |
| 3.17% | 3.98% | 3.16% | 2.47% | 3.91% | 3.27% | 4.12% | 6.49% | 2.35% | 0.21% | |
ROIC |
4.70% | 5.03% | 4.14% | 3.03% | 3.90% | 3.86% | 5.04% | 4.96% | 3.19% | 2.42% |
Return on Tangible Assets |
9.57% | 13.18% | 11.49% | 10.18% | 16.97% | 15.13% | 19.97% | 34.78% | 11.95% | 0.85% |
Average Days of Receivables |
68.15 | 52.15 | 54.27 | 62.05 | 55.91 | 53.82 | 55.70 | 55.73 | 62.60 | 73.99 |
Research and Development Expense of Revenue |
2.67% | 3.11% | 3.98% | 4.49% | 4.26% | 4.52% | 3.70% | 4.00% | 4.30% | 4.45% |
Selling, General and Administrative Expense of Revenue |
11.42% | 10.79% | 11.13% | 11.87% | 11.58% | 10.15% | 11.02% | 11.72% | 12.59% | 12.69% |
Intangible Assets out of Total Assets |
0.57 | 0.58 | 0.60 | 0.64 | 0.67 | 0.68 | 0.69 | 0.71 | 0.60 | 0.67 |
Share Based Compensation of Revenue |
1.25% | 1.44% | 1.50% | 1.58% | 1.33% | 0.85% | 0.74% | 0.86% | 1.29% | 0.78% |
Graham Net Nets |
(0.33) | (0.18) | (0.25) | (0.36) | (0.27) | (0.26) | (0.30) | (0.35) | (1.00) | (1.75) |
Graham Number |
57.48 | 62.13 | 52.82 | 43.88 | 52.03 | 45.23 | 48.50 | 62.14 | 36.66 | 10.04 |
Earnings Yield |
3.72% | 2.69% | 2.77% | 2.92% | 3.42% | 2.89% | 3.68% | 6.82% | 4.63% | 0.64% |
Free Cash Flow Yield |
3.82% | 2.22% | 1.70% | 1.66% | 3.51% | 4.87% | 4.47% | 5.05% | 7.19% | 5.19% |
Revenue per Share |
53.37 | 51.09 | 46.69 | 40.19 | 37.01 | 32.68 | 38.56 | 37.81 | 36.18 | 34.94 |
Operating CF per Share |
5.65 | 6.11 | 5.41 | 3.51 | 4.75 | 5.52 | 5.07 | 5.21 | 4.76 | 3.43 |
Capex per Share |
(2.62) | (3.14) | (3.60) | (2.24) | (1.61) | (1.56) | (1.48) | (1.35) | (1.49) | (1.89) |
Free Cash Flow per Share |
3.03 | 2.96 | 1.81 | 1.28 | 3.14 | 3.96 | 3.59 | 3.85 | 3.27 | 1.54 |
Cash per Share |
0.49 | 1.39 | 0.71 | 0.73 | 0.54 | 1.50 | 0.41 | 0.80 | 1.19 | 1.69 |
Shareholders Equity per Share |
50.28 | 48.19 | 45.59 | 42.79 | 41.06 | 38.70 | 35.32 | 33.00 | 28.45 | 23.56 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
50.28 | 48.19 | 45.59 | 42.79 | 41.06 | 38.70 | 35.32 | 33.00 | 28.45 | 23.56 |
Free Cash Flow |
105.12 | 99.60 | 60.28 | 42.29 | 103.65 | 129.98 | 117.19 | 123.77 | 102.53 | 47.25 |
Working Capital |
538.06 | 443.95 | 396.70 | 334.55 | 293.35 | 256.75 | 236.32 | 251.68 | 322.91 | 332.09 |
Capital Expenditures |
(91.03) | (105.61) | (119.94) | (74.09) | (53.02) | (51.36) | (48.17) | (43.53) | (46.83) | (58.28) |
Net Current Asset Value |
(893.84) | (787.64) | (805.94) | (818.63) | (774.54) | (687.86) | (785.21) | (849.94) | (1,423.05) | (1,590.00) |
EV/EBIT |
17.72 | 26.03 | 25.90 | 28.20 | 26.83 | 27.76 | 21.73 | 21.54 | 23.86 | 27.85 |
Capex to Sales |
0.05 | 0.06 | 0.08 | 0.06 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 |
Price to Operating Income |
12.31 | 21.38 | 20.04 | 20.13 | 20.81 | 22.11 | 16.65 | 15.75 | 11.35 | 9.79 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.26 | 0.25 | 0.27 | 0.30 | 0.32 | 0.33 | 0.35 | 0.60 | 0.48 | 0.26 |
Cash ROIC |
3.53% | 3.72% | 2.40% | 1.78% | 4.69% | 6.34% | 5.92% | 6.15% | 4.04% | 1.88% |
Accounts Receivable Turnover |
6.27 | 7.20 | 6.80 | 6.44 | 7.07 | 6.13 | 6.67 | 6.39 | 5.50 | 4.92 |
Accounts Payable Turnover |
12.61 | 11.45 | 10.01 | 10.50 | 13.77 | 13.52 | 14.79 | 14.00 | 10.98 | 9.09 |
Inventory Turnover |
5.40 | 5.28 | 5.23 | 5.41 | 5.80 | 4.98 | 5.05 | 4.65 | 3.89 | 3.09 |
Average Days of Payables |
30.51 | 29.46 | 37.67 | 41.03 | 31.73 | 23.90 | 26.26 | 24.49 | 30.13 | 38.54 |
Days of Inventory on Hand |
68.44 | 71.73 | 72.98 | 77.32 | 64.28 | 69.19 | 67.60 | 81.40 | 82.49 | 111.38 |
Average Receivables |
295.67 | 238.28 | 228.81 | 206.69 | 172.67 | 175.14 | 188.74 | 190.17 | 206.43 | 218.54 |
Average Payables |
107.31 | 109.88 | 114.52 | 93.82 | 64.21 | 58.27 | 61.08 | 60.87 | 71.22 | 81.13 |
Average Inventory |
250.43 | 238.11 | 218.93 | 182.23 | 152.51 | 158.29 | 178.67 | 183.41 | 200.94 | 238.66 |
Average Assets |
3,244.27 | 3,010.31 | 2,868.52 | 2,688.30 | 2,477.04 | 2,362.48 | 2,339.89 | 2,587.51 | 2,840.44 | 2,907.34 |
Average Common Equity |
1,682.93 | 1,569.13 | 1,468.25 | 1,386.08 | 1,312.88 | 1,211.77 | 1,106.49 | 976.94 | 809.31 | 787.93 |
Columns are period end dates